Pivotal phase III SUNMO study demonstrated an 11.5 month median progression-free survival - three times longer than ...

The decision to advance prasinezumab to Phase III was based on results from the Phase IIb PADOVA trial, which demonstrated ...

The results for Lunsumio, also known as mosunetuzumab, and Polivy, also known as polatuzumab vedotin, came as part of a phase 3 study. Roche said it would now submit results to global health ...

A 51-year-old man stands accused of distributing fentanyl-laced crystal meth to dealers at motels in Hialeah and Opa-Locka.

Genentech, part of the Roche Group (OTCQX:RHHBY), said that a late-stage study testing Lunsumio, along with Polivy, showed ...

"Every refugee was an asylum seeker once", Francis adds. "When you make an application for refugee status, you are an asylum ...

Patriots rookie left tackle Will Campbell may be the new kid in town, but he is loving life in New England. And he's not just ...

When small-cell lung cancer (SCLC) has spread to distant parts of the body, it’s classified as extensive-stage, which applies ...

Analysts at William Blair believe dapiglutide’s 11.6% weight reduction could still be better, given that Zealand’s study ...

In May, the company announced the failure of the monoclonal antibody birtamimab to improve mortality in a phase 3 trial of ...

With a backdrop of mounting industry disruption and transition, Pharm Exec’s latest listing of the top global biopharma sales ...

Cosmetics Business rounds up the top trends and innovations in packaging and ingredients from the two-day event held in ...